Acquisition by Paul Stuka of 225680 shares of InspireMD subject to Rule 16b-3

NSPR Stock  USD 3.00  0.02  0.67%   
Slightly above 51% of InspireMD's investor base is interested to short. The analysis of overall sentiment of trading InspireMD stock suggests that many investors are impartial at this time. InspireMD's investing sentiment overview a quick insight into current market opportunities from investing in InspireMD. Many technical investors use InspireMD stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
  
Filed transaction by Inspiremd Inc director. Grant, award or other acquisition pursuant to Rule 16b-3(d)

Read at macroaxis.com
InspireMD insider trading alert for grant of common stock by Paul Stuka, the corporate stakeholder, on 19th of May 2023. This event was filed by Inspiremd Inc with SEC on 2023-05-19. Statement of changes in beneficial ownership - SEC Form 4

Cash Flow Correlation

InspireMD's cash-flow correlation analysis can be used to evaluate the unsystematic risk during the given period. It also helps investors identify the InspireMD's relationships between the major components of the statement of changes in financial position and other commonly used cash-related accounts. When such correlations are discovered, they may help managers and analysts to enhance performance or determine appealing investment opportunities.
Click cells to compare fundamentals

InspireMD Investor Sentiment by Other News Outlets

Investor sentiment, mood or attitude towards InspireMD can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

InspireMD Fundamental Analysis

We analyze InspireMD's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of InspireMD using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of InspireMD based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Working Capital

Working Capital Comparative Analysis

InspireMD is currently under evaluation in working capital category among its peers. Working Capital is a measure of company efficiency and operating liquidity. The working capital is usually calculated by subtracting Current Liabilities from Current Assets. It is an important indicator of the firm ability to continue its normal operations without additional debt obligations. .

InspireMD Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with InspireMD stock to make a market-neutral strategy. Peer analysis of InspireMD could also be used in its relative valuation, which is a method of valuing InspireMD by comparing valuation metrics with similar companies.

Peers

InspireMD Related Equities

VVOSVivos Therapeutics   6.87   
0%
68.0%
SGHTSight Sciences   6.25   
0%
62.0%
TIVCTivic Health   5.00   
0%
50.0%
NPCENeuropace   3.50   
0%
35.0%
LNSRLENSAR   2.67   
0%
26.0%
AIMDAinos   2.27   
0%
22.0%
SRDXSurModics   0.40   
4.0%
0%
RSLSReShape Lifesciences   0.45   
4.0%
0%
NUWENuwellis   0.99   
9.0%
0%
BJDXBluejay Diagnostics   1.54   
15.0%
0%
BBLGBone Biologics   3.81   
38.0%
0%
IRIXIRIDEX   4.09   
40.0%
0%
TNONTenon Medical   4.17   
41.0%
0%
SSKNSTRATA Skin   5.25   
52.0%
0%
RPIDRapid Micro   10.00   
100.0%
0%

Additional Tools for InspireMD Stock Analysis

When running InspireMD's price analysis, check to measure InspireMD's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy InspireMD is operating at the current time. Most of InspireMD's value examination focuses on studying past and present price action to predict the probability of InspireMD's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move InspireMD's price. Additionally, you may evaluate how the addition of InspireMD to your portfolios can decrease your overall portfolio volatility.